Patents by Inventor Sayaka Asari

Sayaka Asari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for intestinal diseases and visceral pain
    Publication number: 20090270455
    Abstract: The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety:
    Type: Application
    Filed: July 8, 2009
    Publication date: October 29, 2009
    Applicant: AJINOMOTO CO., INC.
    Inventors: Munetaka Tokumasu, Masaki Hashimoto, Tetsuo Yano, Hideki Matsumoto, Shinichi Fujita, Tetsuya Seki, Sayaka Asari, Naoyuki Fukuchi, Kazuyoshi Takahashi, Masataka Shoji
  • NOVEL AZOLE COMPOUND
    Publication number: 20090170911
    Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.
    Type: Application
    Filed: February 20, 2009
    Publication date: July 2, 2009
    Applicant: AJINOMOTO CO. INC
    Inventors: Takashi YAMAMOTO, Akira Chiba, Koichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oomuta, Yuko Iida, Satoshi Iwayama
  • Azole compound
    Patent number: 7517996
    Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: April 14, 2009
    Assignee: Ajinomoto Co., Inc.
    Inventors: Takashi Yamamoto, Akira Chiba, Koichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oomuta, Yuko Iida, Satoshi Iwayama
  • Novel piperidine derivative
    Publication number: 20070021460
    Abstract: The present invention provides a piperidine derivative represented by the following formula or analogs thereto, which are used for agents for treating or preventing various diseases related to 5-HT7.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 25, 2007
    Inventors: Shingo Makino, Naoyuki Fukuchi, Sayaka Asari, Masaki Hashimoto, Tetsuo Yano, Youji Yamada, Munetaka Tokumasu, Masataka Shoji, Itsuya Tanabe, Shinichi Fujita, Hideki Matsumoto
  • Novel azole compound
    Publication number: 20060194850
    Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.
    Type: Application
    Filed: February 3, 2006
    Publication date: August 31, 2006
    Applicant: AJINOMOTO CO. INC
    Inventors: Takashi Yamamoto, Akira Chiba, Kouichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oohmuta, Yuko Iida, Satoshi Iwayama
  • Therapeutic agent for intestinal diseases and visceral pain
    Publication number: 20050148632
    Abstract: The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety:
    Type: Application
    Filed: February 7, 2005
    Publication date: July 7, 2005
    Inventors: Munetaka Tokumasu, Masaki Hashimoto, Tetsuo Yano, Hideki Matsumoto, Shinichi Fujita, Tetsuya Seki, Sayaka Asari, Naoyuki Fukuchi, Kazuyoshi Takahashi, Masataka Shoji